Histopath Diagnostic Specialists Revenue and Competitors
Estimated Revenue & Valuation
- Histopath Diagnostic Specialists's estimated annual revenue is currently $55.2M per year.
- Histopath Diagnostic Specialists's estimated revenue per employee is $297,000
Employee Data
- Histopath Diagnostic Specialists has 186 Employees.
- Histopath Diagnostic Specialists grew their employee count by -13% last year.
Histopath Diagnostic Specialists's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Business Manager | Reveal Email/Phone |
3 | Laboratory Technician | Reveal Email/Phone |
4 | Team Leader - Molecular | Reveal Email/Phone |
Histopath Diagnostic Specialists Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $42.8M | 144 | 20% | N/A | N/A |
#2 | $108M | 320 | 20% | N/A | N/A |
#3 | $185M | 548 | 7% | N/A | N/A |
#4 | $79M | 266 | 49% | N/A | N/A |
#5 | $26.5M | 98 | 5% | N/A | N/A |
#6 | $50.2M | 169 | 5% | N/A | N/A |
#7 | $229.8M | 681 | 1% | N/A | N/A |
#8 | $60.9M | 205 | 27% | N/A | N/A |
#9 | $53.8M | 181 | 5% | N/A | N/A |
#10 | $14.8M | 61 | 3% | N/A | N/A |
What Is Histopath Diagnostic Specialists?
Established in 1998, Histopath is one of Sydney’s largest independent providers of Specialist Pathology services incorporating the highest standards and ethics in the context of a fully independent, accredited laboratory. Histopath’s team of Pathologists, 40 staff and independent couriers, provide medical consultation to thousands of patients every year, on behalf of a large number of Specialist Doctors and GPs throughout the metropolitan area and the Central Coast. Unlike most pathology laboratories, which provide predominantly automated testing of blood samples, or general pathology, Histopath differs by being a market leader in a specialised sub-branch of pathology. Histopath’s surgical pathology services involve the gross and microscopic examination of patient tissue specimens which are submitted by Surgeons and GPs. This allows for the definitive diagnosis or exclusion of diseases, such as cancer. Tissue specimens are processed by scientists and then examined by specialist doctors. Examination of the tissue may involve evaluation of molecular properties by immunohistochemistry or other laboratory tests. Being privately owned by doctors, there is a primary focus on patient care. Pathology is a significant growth area in medicine and due to its ability to respond to the rapidly changing needs and complexity of the health care environment, Histopath continues to experience significant growth.
keywords:N/AN/A
Total Funding
186
Number of Employees
$55.2M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $31.2M | 218 | -54% | $95.6M |
#2 | $35.9M | 225 | -5% | N/A |
#3 | $58.4M | 253 | 0% | N/A |
#4 | $29.6M | 269 | 7% | N/A |
#5 | $35M | 294 | 18% | N/A |